ImmunoGen, Inc. (NASDAQ:IMGN) Q2 2023 Earnings Call Transcript July 31, 2023
ImmunoGen, Inc. misses on earnings expectations. Reported EPS is $-0.24 EPS, expectations were $-0.14.
Operator: Good morning and welcome to ImmunoGen’s second quarter 2023 financial and operating results conference call. Today’s conference is being recorded. At this time, I’d like to turn the call over to Anabel Chan, Head of Investor Relations. Please go ahead.
Anabel Chan: Good morning and thank you for...
